News

• Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  04/01/2021 / 22:01 - GlobeNewswire
•  
• Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications
  03/24/2021 / 12:00 - GlobeNewswire
•  
• Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  03/01/2021 / 22:01 - GlobeNewswire
•  
• Athenex Provides Fourth Quarter and Full Year 2020 Corporate and Financial Update
  03/01/2021 / 13:05 - GlobeNewswire
•  
• Paratek Pharmaceuticals Announces Full Year 2020 Total Revenue of $46.9 Million including NUZYRA® (omadacycline) Net U.S. Sales of $38.8 Million
  02/24/2021 / 22:01 - GlobeNewswire
•  
• Paratek Pharmaceuticals to Present at the 10th Annual SVB Leerink Global Healthcare Conference
  02/18/2021 / 22:01 - GlobeNewswire
•  
• Athenex Announces U.S. Launch of Klisyri® and Licensing of Additional Territories for Tirbanibulin
  02/18/2021 / 13:55 - GlobeNewswire
•  
• Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on February 24, 2021
  02/17/2021 / 22:01 - GlobeNewswire
•  
• Athenex Announces New England Journal of Medicine Publication of Phase III Data on the Efficacy and Safety of Klisyri® (tirbanibulin)
  02/11/2021 / 13:00 - GlobeNewswire
•  
• Paratek Announces Expansion of NUZYRA® Launch into the Community Setting
  02/08/2021 / 14:00 - GlobeNewswire
•  
• Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  02/01/2021 / 22:05 - GlobeNewswire
•  
• Paratek Pharmaceuticals to Present at the 2021 H.C. Wainwright BIOCONNECT Virtual Conference
  01/06/2021 / 14:00 - GlobeNewswire
•  
• Paratek Pharmaceuticals Receives $60 Million Non-Recourse Loan from R-Bridge Healthcare Investment Advisory, Ltd., an affiliate of CBC Group
  01/04/2021 / 23:00 - GlobeNewswire
•  
• Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
  12/15/2020 / 13:00 - GlobeNewswire
•  
• Pulmonx Welcomes Two New Members to Its Board of Directors, Adding Expertise in Consumer Marketing and Medical Device Company Growth
  12/08/2020 / 14:13 - GlobeNewswire